West Oak Capital’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

West Oak Capital’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-50	Closed	-$209	–	294
2015 Q3	$209	Hold	50	–	–	﹤0.01%	288
2015 Q2	$264	Buy	+50	New	+$320	﹤0.01%	300

Other funds holding OCAT

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

West Oak Capital's OCAT Position: Q4 2015 in Review

West Oak Capital sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q4 2015, closing a stake of 50 shares — an estimated $209 sold.

West Oak Capital first reported a position in OCAT in Q2 2015 and held it in 2 quarters. The position peaked at $264 in Q2 2015. 77 funds tracked by Wall St. Rank hold OCAT as of Q4 2015.

West Oak Capital reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q4 2015 after selling out during the quarter.
West Oak Capital sold 50 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q4 2015, an estimated $209.
West Oak Capital first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 2 quarters.
West Oak Capital's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $264 in Q2 2015.
77 funds tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q4 2015.

Based on West Oak Capital's 13F filing for Q4 2015, filed 7 Jan 2016.